Catheter Precision (VTAK) Stock Price

Catheter Precision Price

ASX·CLOSED
1.01
​
Market closed

Revenue at Catheter Precision has contracted by 19.8% per year over the past 9 years to 819,000.00 USD. For Catheter Precision, the net margin of -2,098.0% is up versus -113,954.5% a few years ago. The consensus 12-month price target for Catheter Precision is 2.04 USD, about 102.0% above where the stock trades today. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.

Catheter Precision stock price

Access this data via the Eulerpool API

Catheter Precision business model & stock analysis

Ra Medical Systems, Inc. engages in the design, development and commercialization of excimer lasers for the treatment of vascular immune-mediated inflammatory diseases. The company is headquartered in Fort Mill, South Carolina and currently employs 14 full-time employees. The company went IPO on 2018-09-27. The firm is engaged in providing new solutions to the market to improve the treatment of cardiac arrhythmias. The firm is focused on developing technology for electrophysiology procedures by collaborating with physicians and advancing its products. The company is developing and delivering electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias. Its products include Amigo, VIVO, and LockeT. Amigo is a remote catheter system, which uses an open architecture design, making it possible to use the system for additional catheter procedures. VIVO is a non-invasive three-dimensional (3D) imaging system that enables physicians to identify the origin of arrhythmias pre-procedure, streamlining workflow and reducing overall procedure time. LockeT is a suture retention device intended for wound healing.

Frequently asked questions about Catheter Precision

Analysts currently set an average price target of 2.04 USD for the Catheter Precision stock (median: 2.04 USD), implying +102.0 % versus the latest price. The consensus is based on 7 analyst ratings.

7 analysts currently rate the Catheter Precision stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Catheter Precision to generate revenue of 10.23 M USD and earnings per share of -0.00 USD.

Converted at the current exchange rate, the Catheter Precision share trades at 0.90 EUR (1.01 USD).

The Catheter Precision share (VTAK) is listed on 3 stock exchanges, including: ASX (VTAK), Frankfurt (4RM.F), München (4RM.MU).

The expected revenue of Catheter Precision is 10.23 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Catheter Precision is -53,440.00 USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Catheter Precision is currently -2,042.33. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Catheter Precision stock.

The price-to-sales ratio (P/S) of Catheter Precision is currently 10.67. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Catheter Precision stock.

The Eulerpool Quality Score for Catheter Precision is 3/10.

The ISIN of Catheter Precision is US74933X7084. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Catheter Precision is A3DWG8. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Catheter Precision is VTAK. The ticker symbol is used to trade Catheter Precision shares on the stock exchange.

Fair ValueTerminal
0.86 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
58,500.00 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website ramed.com
Currency
USD
Initial public offering
Sep 27, 2018
ISIN
US74933X7084
Cusip
74933X302
Market capitalization
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-2,042.33
P/Se
10.67
EV/EBIT
—
P/B Ratio
0.02
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-157.64 %
Last updated Oct 10, 2026, 5:12 AM

Catheter Precision Peer Group

Catheter Precision Ticker

AUSTRALIEN SECURITIES · VTAKFRANKFURT · 4RM.FMUNICH · 4RM.MU